Characteristics | Before intervention | After intervention | ||||
---|---|---|---|---|---|---|
Control site, no. | Intervention site, no. | P value (chi-square) | Control site, no. | Intervention site, no. | P value (chi-square) | |
Sex | ||||||
Male | 67 | 59 | 0.077 | 77 | 99 | 0.658 |
Female | 49 | 44 | 59 | 68 | ||
Total | 116 | 103 | 136 | 167 | ||
Age categories | ||||||
15–24 years old | 23 | 12 | 0.099 | 23 | 32 | 0.147 |
25–34 years old | 39 | 44 | 43 | 51 | ||
35–44 years old | 29 | 23 | 32 | 41 | ||
45–54 years old | 13 | 16 | 17 | 27 | ||
> 55 years old | 12 | 8 | 21 | 16 | ||
HIV status | ||||||
Positive | 72 | 84 | 0.010 | 72 | 139 | 0.010 |
Negative | 44 | 19 | 64 | 28 | ||
Highly active antiretroviral treatment (HAART) | ||||||
On HAART | 11 | 37 | 0.001 | 41 | 73 | 0.001 |
Not on HAART | 105 | 66 | 95 | 94 | ||
History of TB treatment and sensitivity to drugs | ||||||
New case | 77 | 66 | 0.106 | 78 | 91 | 0.106 |
Relapse | 33 | 25 | 43 | 45 | ||
MDR TB | 6 | 12 | 15 | 31 |